{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:05:01Z","timestamp":1649210701422},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00105-005-0927-4","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T18:07:29Z","timestamp":1110823649000},"page":"441-447","source":"Crossref","is-referenced-by-count":4,"title":["Sentinel-Node-Biopsie"],"prefix":"10.1007","volume":"56","author":[{"given":"M.","family":"M\u00f6hrle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Breuninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000658-199602000-00016","volume":"223","author":"Albertini","year":"1996","unstructured":"Albertini JJ, Cruse CW, Rapaport D et al. (1996) Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217\u2013224","journal-title":"Ann Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0960-7404(06)80006-X","volume":"2","author":"Alex","year":"1993","unstructured":"Alex JC, Weaver DL, Fairbank JT et al. (1993) Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2:303\u2013308","journal-title":"Surg Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR3","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635\u20133648","journal-title":"J Clin Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR4","unstructured":"Balch CM, Cascinelli N, Sim FH et al. (1998) Elektive lymph node dissektion: results of prospective randomized surgical trials. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (eds) Cutaneous melanoma. Quality Medical Publishing, St. Louis, pp. 209\u2013225"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"Balch","year":"1996","unstructured":"Balch CM, Soong SJ, Bartolucci AA et al. (1996) Efficacy of an elective regional lymph node dissection of 1 to 4\u00a0mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255\u2013263","journal-title":"Ann Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000658-198212001-00011","volume":"196","author":"Balch","year":"1982","unstructured":"Balch CM, Soong SJ, Milton GW et al. (1982) A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196:677\u2013684","journal-title":"Ann Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","volume":"2","author":"Balch","year":"2000","unstructured":"Balch CM, Soong SJ, Ross MI et al. (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0\u00a0mm). Ann Surg Oncol 2:87\u201397","journal-title":"Ann Surg Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1523-1747.2000.00925.x","volume":"114","author":"Blaheta","year":"2000","unstructured":"Blaheta HJ, Ellwanger U, Schittek B et al. (2000) Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 114:637\u2013642","journal-title":"J Invest Dermatol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR9","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/1097-0142(20000601)88:11<2534::AID-CNCR15>3.0.CO;2-2","volume":"88","author":"Blum","year":"2000","unstructured":"Blum A, Schlagenhauff B, Stroebel W et al. (2000) Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer 88:2534\u20132539","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR10","first-page":"759","volume":"24","author":"Breuninger","year":"1998","unstructured":"Breuninger H, Wehner CJ (1998) Slow infusion tumescent anesthesia [see comments]. Dermatol Surg 24:759\u2013763","journal-title":"Dermatol Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR11","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1200\/JCO.1995.13.9.2361","volume":"13","author":"Buzaid","year":"1995","unstructured":"Buzaid AC, Tinoco LA, Jendiroba D et al. (1995) Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 13:2361\u20132368","journal-title":"J Clin Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I","volume":"39","author":"Cabanas","year":"1977","unstructured":"Cabanas R M (1977) An approach for the treatment of penile carcinoma. Cancer 39:456\u2013466","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10434-000-0469-z","volume":"7","author":"Cascinelli","year":"2000","unstructured":"Cascinelli N, Belli F, Santinami M et al. (2000) Sentinel lymph node biopsy in cutaneous melanoma: The WHO Melanoma Program experience. Ann Surg Oncol 7:469\u2013474","journal-title":"Ann Surg Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M et al. (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351:793\u2013796","journal-title":"Lancet"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1097-0142(20000715)89:2<236::AID-CNCR5>3.0.CO;2-0","volume":"89","author":"Cochran","year":"2000","unstructured":"Cochran AJ, Balda BR, Starz H et al. (2000) The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 89:236\u2013241","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/1097-0142(19810301)47:5<955::AID-CNCR2820470523>3.0.CO;2-1","volume":"47","author":"Day-CL","year":"1981","unstructured":"Day-CL J, Sober AJ, Lew RA et al. (1981) Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 47:955\u2013962","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s10434-001-0766-1","volume":"8","author":"Dessureault","year":"2001","unstructured":"Dessureault S, Soong SJ, Ross MI et al. (2001) Improved staging of node-negative patients with intermediate to thick melanomas (>1\u00a0mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 8:766\u2013770","journal-title":"Ann Surg Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/1097-0142(19930801)72:3<741::AID-CNCR2820720318>3.0.CO;2-W","volume":"72","author":"Drepper","year":"1993","unstructured":"Drepper H, K\u00f6hler CO, Bastian B et al. (1993) Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer 72:741\u2013749","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF02574479","volume":"9","author":"Ferrone","year":"2002","unstructured":"Ferrone CR, Panageas KS, Busam K et al. (2002) Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 9:637\u2013645","journal-title":"Ann Surg Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archsurg.134.4.381","volume":"134","author":"Gadd","year":"1999","unstructured":"Gadd MA, Cosimi AB, Yu J et al. (1999) Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134:381\u2013387","journal-title":"Arch Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"Gershenwald","year":"1999","unstructured":"Gershenwald JE, Thompson W, Mansfield PF et al. (1999) Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976\u2013983","journal-title":"J Clin Oncol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaad.2003.07.016","volume":"50","author":"Karimipour","year":"2004","unstructured":"Karimipour DJ, Lowe L, Su L et al. (2004) Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol 50:759\u2013764","journal-title":"J Am Acad Dermatol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2003.07.003","volume":"40","author":"Kretschmer","year":"2004","unstructured":"Kretschmer L, Hilgers R, M\u00f6hrle M et al. (2004) Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 40:212\u2013218","journal-title":"Eur J Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR24","first-page":"An","volume":"melanoma","author":"Medalie","year":"2003","unstructured":"Medalie N, Ackerman AB (2003) Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma: An assertion based on comprehensive critical analysis. Ardor Scribendi, New York","journal-title":"Sentinel lymph node biopsy has no benefit for patients with primary cutaneous"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0190-9622(99)70004-6","volume":"41","author":"Moehrle","year":"1999","unstructured":"Moehrle M, Blum A, Rassner G, Juenger M (1999) Lymph node metastases of cutaneous melanoma: diagnosis by B-scan and color Doppler sonography. J Am Acad Dermatol 41:703\u2013709","journal-title":"J Am Acad Dermatol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR26","first-page":"1319","volume":"30","author":"Moehrle","year":"2004","unstructured":"Moehrle M, Schippert W, Garbe C et al. (2004) Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant metastasis-free survival and overall survival. Dermatol Surg 30:1319\u20131328","journal-title":"Dermatol Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR27","first-page":"5","volume":"209","author":"M","year":"1905","unstructured":"M\u00f6hrle M, Schippert W, Rassner G et al. (2004) Is sentinel lymph node biopsy of therapeutic relevance for melanoma? Dermatology 209:5\u201313","journal-title":"Dermatology"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2133.2004.06133.x","volume":"151","author":"Morton","year":"2004","unstructured":"Morton DL, Cochran AJ (2004) The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol 151:308\u2013319","journal-title":"Br J Dermatol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH et al. (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392\u2013399","journal-title":"Arch Surg"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1067\/S0190-9622(03)02136-4","volume":"49","author":"Perrott","year":"2003","unstructured":"Perrott RE, Glass LF, Reintgen DS, Fenske NA (2003) Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol 49:567\u2013588","journal-title":"J Am Acad Dermatol"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1067\/msy.2000.107418","volume":"128","author":"Porter","year":"2000","unstructured":"Porter GA, Ross MI, Berman RS et al. (2000) How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery 128:306\u2013311","journal-title":"Surgery"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(12)62768-2","volume":"61","author":"Sim","year":"1986","unstructured":"Sim FH, Taylor WF, Pritchard DJ, Soule EH (1986) Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61:697\u2013705","journal-title":"Mayo Clin Proc"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR33","unstructured":"Soong SJ, Weiss HL (1998) Predicting outcome in patients with localized melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (eds) Cutaneous melanoma. Quality Medical Publishing, St. Louis, pp 51\u201361"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR34","unstructured":"Stadelmann WK, Rapaport DP, Soong SJ et al. (1998) Prognostic clinical and pathologic features. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (eds) Cutaneous melanoma. Quality Medical Publishing, St. Louis, pp 11\u201335"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR35","doi-asserted-by":"crossref","unstructured":"Starz H, Balda BR, Kramer KU et al. (2001) Micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001a; 91:2210\u20132220","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR36","unstructured":"Starz, H., De-Donno, A.,Balda, B.R. The Augsburg experience: histological aspects and patient outcomes. Ann Surg Oncol 8:48S\u201351S"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR37","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I","volume":"91","author":"Statius","year":"2001","unstructured":"Statius Muller MG, van-Leeuwen PA, de-Lange-De-Klerk ES et al. (2001) The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer 91:2401\u20132408","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","volume":"351","author":"Tsao","year":"2004","unstructured":"Tsao H, Atkins MB, Sober AJ (2004) Management of cutaneous melanoma. N Engl J Med 351:998\u20131012","journal-title":"N Engl J Med"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR39","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","volume":"49","author":"Veronesi","year":"1982","unstructured":"Veronesi U, Adamus J, Bandiera DC et al. (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420\u20132430","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0142(20000715)89:2<453::AID-CNCR34>3.0.CO;2-V","volume":"89","author":"Wagner","year":"2000","unstructured":"Wagner JD, Gordon MS, Chuang TY et al. (2000) Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 89:453\u2013462","journal-title":"Cancer"},{"key":"PEIWorkflow-105-56-5_2005-05-10_14-48-08_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archotol.126.3.313","volume":"126","author":"Wagner","year":"2000","unstructured":"Wagner JD, Park HM, Coleman JJ et al. (2000) Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg 126:313\u2013321","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-0927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-005-0927-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-0927-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:05Z","timestamp":1558582625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-005-0927-4"}},"subtitle":["Welche Aussagen sind gesichert?"],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1007\/s00105-005-0927-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}